
- 中国科技核心期刊
- 中国科技论文统计源期刊
- RCCSE中国核心学术期刊
- 美国《化学文摘》(CA)收录期刊
- 英国《国际农业与生物科学研究中心》(CABI)收录期刊
- 美国《乌利希国际期刊指南(网络版)》收录期刊
- 全军优秀医学期刊
- 中国科技核心期刊
- 中国科技论文统计源期刊
- RCCSE中国核心学术期刊
- 美国《化学文摘》(CA)收录期刊
- 英国《国际农业与生物科学研究中心》(CABI)收录期刊
- 美国《乌利希国际期刊指南(网络版)》收录期刊
- 全军优秀医学期刊
利多卡因凝胶在男性患者膀胱灌注化疗中的应用
Lidocaine Gel Application in Male Patients with Bladder Irrigation Chemotherapy
【摘要】目的?探讨利多卡因凝胶在男性患者膀胱灌注化疗中的效果。方法?80例膀胱癌术后灌注化疗患者为对象,随机分为两组,实验组(利多卡因凝胶组)在灌注导尿前进行利多卡因凝胶尿道润滑、表面麻醉,对照组(常规组)则按常规使用石蜡油润滑导尿法灌注。结果?实验组在一次性置管成功率、疼痛程度、化疗药液保留时间等方面明显优于对照组组,有差异性(p<0.05)。结论?采用利多卡因凝胶进行尿道润滑、局部麻醉,有显著的镇痛和润滑效果,可减轻患者痛苦,提高插管成功率和延长灌注药物保留时间,是提高疗效及灌注依从性的有效措施之一。
【Abstract】[英文摘要部分句子需修改,一般objective,methods,results里面用一般过去时态。可参考我刊网刊文章进行修改] Objective To discuss the efficiency of lidocaine gel in male patients with bladder irrigation chemotherapy. Methods. A total of eighty patients with bladder cancer were randomly divided into two groups, who received the treatment of bladder irrigation chemotherapy after operation. The patients in experimental group were infused lidocaine hydrochloride gel into urethra for mucosa surface anesthesia and lubrication before insertting catheter,while the patients in control group were treated with insertting catheter after using liquid lubrication oil. Results The one-time success rate of insertting catheter, the degree of pain, the chemotherapy liquid retention time in the experimental group were significantly better than those in the control group. There were statistical significance between the two groups (P<0.05). Conclusions Lidocaine gel could alleviate the suffering of patients, improve the one-time success rate of insertting catheter and prolong the retention time of the drug infusion for significant analgesic and lubrication effect. Lidocaine gel application in male patients with bladder irrigation chemotherapy was one of the effective measures to improve curative efficacy and irrigation compliance.
【关键词】利多卡因 / 膀胱癌 / 膀胱灌注 {{custom_keyword}} /
【Key words】 Lidocaine / Bladder cancer / Bladder irrigation {{custom_keyword}} /
[1] Babjuk M, Burger M,Zigeuner R,et al.EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder:Update 2013[J].Eur Urol,2013,64(4):639–653.
[2]Anastasiadis A,de Reijke TM.Best practice in the treatment of nonmuscle invasive bladder cancer[J]. Ther Adv Urol, 2012;4(1):13–32
[3]Barlow LJ, Benson MC.Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer[J]. Curr Urol Rep,14(2): 65–70.
[4] GriffinJG , HolzbeierleinJ..Sideeffects of perioperativeintravesical treatment and treatment strategies for these side effects[J]. Urol Clin North Am, 2013,40(2):197-210.
[5] 李三祥,谭朝晖,刘俊峰,等非肌层浸润性膀胱癌术后即刻吡柔比星灌注临床观察[J].内蒙古医学杂志,2012,44(3):283-285.
[6]陈蜡金,林昭.膀胱癌术后膀胱灌注护理总结[J].实用中医药杂志,2012,28(10):878-879.
[7]闫秀峰. 膀胱肿瘤术后化疗药物膀胱灌注的观察和护理[J].实用药物与临床,2012,20(3):552-553.
[8] 张燕,石远凯主编.临床肿瘤内科手册[M].第5版.北京:人民卫生出版社,2009:258-259.
[9]毛金水.金葡素加羟喜树碱灌注化疗对预防浅表性膀胱癌术后复发的疗效[J].海峡药学,2012,24(8):196-197.
[10]KaufmanDS,ShipleyWU,FeldmanAS.Bladdercancer[J].Lancet,2009,374(9685):239-249.
[11]付喜秀.影响膀胱癌灌注药物保留时间的原因分析与护理[J].中国癌症防治杂志,2010,2(4):316-317.
[12]周翠鸾,田 帅.膀胱癌患者行膀胱灌注应用盐酸利多卡因凝胶留置尿管的效果观察[J].中华保键医学杂志,2009,11(1):41-42
/
〈 |
|
〉 |